Login to Your Account



Centocor’s Remicade Receives Third Rheumatoid Arthritis Nod

By Brady Huggett


Friday, March 1, 2002
Centocor Inc.’s Remicade is inflating - both in uses and sales - having received a third approval in a rheumatoid arthritis indication. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription